Paul Mullan

Phone+44 (0)28 9097 2941
EmailP.Mullan@qub.ac.uk

Room 02.005 - CCRCB
United Kingdom

Accepting PhD Students

PhD projects

Dr Mullan's group is open to wide-ranging PhD applications from candidates with a basic science or clinical background. His fields of interest include: - Molecular Oncology - Cancer Biology and Signal Transduction - Drug discovery and development - Biomarkers, diagnosis and early detection of cancer Previous research experience is desirable although not essential.

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active
3 Finished

4 results

Active

R1944CNR: The identification and testing of blood markers to detect the presence of early ovarian stage cancers, speeding up patient diagnosis and ultimately improving patient survival.
Mullan, P. & Beirne, J. P.
06/09/2018 → …
Project: Research
Finished

R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Harrison, T., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Waugh, D., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer
Kennedy, R. & Mullan, P.
01/08/2012 → 28/03/2015
Project: Research

Search results

R1944CNR: The identification and testing of blood markers to detect the presence of early ovarian stage cancers, speeding up patient diagnosis and ultimately improving patient survival.

R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB

R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB

R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer